What is Preeclampsia?
Preeclampsia is a disease associated with hypertension during pregnancy that can occur as early as 20 weeks and produces complications in both the mother and the fetus, such as placental abruption, premature delivery, organ failure or seizures, among others.
Preeclampsia is a serious complication in 3 to 5% of pregnancies, requiring induction of labor before the 34th week of gestation (early preeclampsia) or at the end of pregnancy (late preeclampsia).
Early detection and clear risk stratification facilitates decision making to ensure the well-being of the mother and fetus.
– HYPERTENSION (systolic and diastolic) in previously normotensive women.
– PROTEINURIA: presence of protein in the urine in a higher concentration than normal.
– EDEMA: accumulation of liquids.
– DECREASED RENAL FUNCTION
– HEPATIC INVOLVEMENT
For which women is it indicated?
This test is indicated for all pregnant women from the 20th week of pregnancy, especially if they present any of the following risk factors:
– First pregnancy or first pregnancy with a new partner
– Preeclampsia in previous pregnancy
– Multiple pregnancy
– Pregnancy by in vitro fertilization
– Diabetes mellitus type I
– Women over 40 years old
– Kidney problems
– Family history of cardiovascular disease
– Antiphospholipid antibody syndrome
– Lupus erythematosus
The results of the study are essential for the physician to be able to act in time, through a diagnosis of two possible outcomes: Diagnosis of preeclampsia | Possible risk
Diagnosis of preeclampsia: evidence of the syndrome, assessment of severity and progression; allowing rapid medical action in favor of mother and baby.
Possible risk: risk of developing preeclampsia or not in the next 4 weeks, so the pregnant woman is kept under medical surveillance.
The Elecsys sFlt-1/PIGF ratio measurement is a reliable tool to identify those women at high risk of developing preeclampsia in the next 4 weeks and who require closer monitoring. On the other hand, it allows the detection of women with suspected preeclampsia who will not develop the disease within a week. The sFlt-1/PIGF ratio serves to differentiate preeclampsia/HELP from different forms of hypertensive disorders of pregnancy.
- Reservation: 9 € (included in the total amount)
- Amount: 95 €.
It is included:
- Clinical analysis.
- Results report.